Sjoberg E R, Manzi A E, Khoo K H, Dell A, Varki A
Department of Medicine, University of California, La Jolla 92093.
J Biol Chem. 1992 Aug 15;267(23):16200-11.
We have shown previously that Golgi-enriched vesicles from the human melanoma cell line Melur can transfer [3H]acetate from [acetyl-3H]acetyl-CoA to endogenous GD3 to form [acetyl-3H]O-acetyl-GD3 (Manzi, A. E., Sjoberg, E. R., Diaz, S., and Varki, A. (1990) J. Biol. Chem. 265, 13091-13103). Applying the same approach in the human melanoma cell line M21, label was found in [acetyl-3H]O-acetyl-GD3 and also in a species co-migrating with unsubstituted GD3 on TLC. Both were sialidase-sensitive and alkali-labile, indicating incorporation as [3H]O-acetyl esters on sialic acids. Immunological reactivity, sialidase sensitivity, chromatographic behavior, and the known ganglioside pattern of M21 cells suggested that the slower migrating species might be [acetyl-3H]O-acetyl-GD2. Sialic acids released from this labeled molecule by sialidase showed esterification with [3H]acetate at both C7 and C9 hydroxyls. Lipid extracts from cells metabolically labeled with [3H]galactose showed a corresponding ganglioside, which upon alkali treatment yielded a species migrating with GD2. Analysis of purified ganglioside by high performance thin layer chromatography immuno-overlays, fast atom bombardment-mass spectrometry in positive and negative ion modes, periodate oxidation resistance, linkage analysis by permethylation and gas chromatography-mass spectrometry, and 500 MHz 1H NMR was consistent with the following structure: 9-O Ac-Neu5Ac alpha 2-8Neu5Ac alpha 2-3(GalNAc beta 1-4) Gal beta 1-4Gluc beta 1-1' ceramide Total gangliosides from M21 were analyzed by high performance thin layer chromatography immuno-overlay with monoclonal antibodies D1.1, JONES, 27A, and 8A2, all known to, or suspected of reacting with 9-O-acetylated gangliosides. The first three bound well to 9-O-acetyl-GD3 and a slower migrating 9-O-acetylated ganglioside, which was distinct from 9-O-acetyl-GD2. Antibody 8A2 reacted weakly with purified 9-O-acetyl-GD2 and strongly with two other 9-O-acetylated gangliosides migrating slower than 9-O-acetyl-GD2. Thus, the family of O-acetylated gangliosides in melanoma cells is much more complex than previously appreciated.
我们之前已经表明,来自人黑色素瘤细胞系Melur的富含高尔基体的囊泡可以将[3H]乙酸从[乙酰基-3H]乙酰辅酶A转移到内源性GD3上,形成[乙酰基-3H]O-乙酰基-GD3(曼齐,A.E.,肖伯格,E.R.,迪亚兹,S.,和瓦尔基,A.(1990年)《生物化学杂志》265,13091 - 13103)。在人黑色素瘤细胞系M21中采用相同方法,在[乙酰基-3H]O-乙酰基-GD3以及在薄层层析(TLC)上与未取代的GD3共迁移的一个组分中发现了放射性标记。两者都对唾液酸酶敏感且对碱不稳定,表明是以[3H]O-乙酰酯的形式掺入到唾液酸上。M21细胞的免疫反应性、对唾液酸酶的敏感性、色谱行为以及已知的神经节苷脂模式表明,迁移较慢的组分可能是[乙酰基-3H]O-乙酰基-GD2。唾液酸酶从这个标记分子释放出的唾液酸在C7和C9羟基处都显示与[3H]乙酸发生了酯化。用[3H]半乳糖进行代谢标记的细胞的脂质提取物显示出一种相应的神经节苷脂,经碱处理后产生一种与GD2迁移相同的组分。通过高效薄层层析免疫叠加、正离子和负离子模式的快原子轰击质谱、耐高碘酸盐氧化、通过全甲基化和气相色谱-质谱进行的连接分析以及500兆赫兹1H核磁共振对纯化的神经节苷脂进行分析,结果与以下结构一致:9-O-乙酰基-Neu5Acα2-8Neu5Acα2-3(GalNAcβ1-4)Galβ1-4Glucβ1-1'神经酰胺。用单克隆抗体D1.1、琼斯、27A和8A2对M21细胞的总神经节苷脂进行高效薄层层析免疫叠加分析,所有这些抗体已知或怀疑与9-O-乙酰化神经节苷脂发生反应。前三种抗体与9-O-乙酰基-GD3以及一种迁移较慢的9-O-乙酰化神经节苷脂结合良好,该神经节苷脂与9-O-乙酰基-GD2不同。抗体8A2与纯化的9-O-乙酰基-GD2反应较弱,而与另外两种迁移比9-O-乙酰基-GD2慢的9-O-乙酰化神经节苷脂反应强烈。因此,黑色素瘤细胞中O-乙酰化神经节苷脂家族比之前所认识到的要复杂得多。